Okulära lokalanestetika
Granskad av Dr Toni Hazell, MRCGPSenast uppdaterad av Dr Hayley Willacy, FRCGP Senast uppdaterad 29 Dec 2022
Uppfyller patientens redaktionella riktlinjer
- Ladda nerLadda ner
- Dela
- Language
- Diskussion
- Ljudversion
- Lägg till i föredragna källor på Google
Medicinska yrkesverksamma
Professionella referensartiklar är utformade för att användas av hälso- och sjukvårdspersonal. De är skrivna av brittiska läkare och baserade på forskningsbevis, brittiska och europeiska riktlinjer. Du kanske hittar en av våra hälsoartiklar mer användbar.
What are local anaesthetics?
Local anaesthetics (LAs) numb sensation (or pain), and when used on the eye have several functions. They are used:
In the initial assessment of minor eye trauma.
For the removal of superficial foreign bodies.
For the measurement of intraocular pressure using applanation tonometry.
For ocular surgery.
For the correction of small angle deviation strabismus.1
These agents should not be used for long-term management of ocular pain: they are toxic to the corneal epithelium. They also abolish the corneal reflex so increasing the risk of corneal damage. Topical non-steroidal anti-inflammatory drugs (NSAIDs), such as diclofenac eye drops, may have some role in pain management but their efficiency is uncertain and they should not be used as a substitute for oral analgesia (paracetamol, oral NSAIDs).2
LAs work by blocking initiation and propagation of neuronal action potentials. Small-diameter, myelinated nerves are most susceptible to LA action - but not exclusively so - and therefore patients will often report preservation of sensory modalities other than pain.
See also the separate Eye Injuries, Corneal Foreign Bodies, Injuries and Abrasions och Diagnosing Conjunctival Problems articles.
Anaesthetic drops
There are a number of anaesthetic drops available. Subtle differences between them make them more or less appropriate in different individuals. New drops appear in the literature from time to time.
Examples - lidocaine hydrochloride, oxybuprocaine hydrochloride, proxymetacaine hydrochloride, tetracaine hydrochloride (amethocaine hydrochloride).2
Användning - largely for initial assessment of minor trauma and for removal of conjunctival and corneal foreign bodies. Their use in surgery, particularly cataract surgery, is becoming the norm with surgeons citing patient comfort and ease of technique.3 .
Contra-indications - known hypersensitivity reaction, neonates.
Caution - hypertensive patients.4
Administration - these come in single-dose preparations. Warn the patient of brief stinging on application: proxymetacaine stings a little less (useful in highly anxious patients and children). Tetracaine produces a more profound anaesthesia. Pain that is not relieved by topical LA suggests a more serious problem than superficial corneal or conjunctival injury.2
Ocular side-effects - transient stinging; epithelial and stromal keratitis if overused. 4 They are, however, known to inhibit corneal epithelial cell healing and so interfere with repair of corneal epithelial wounds. Tetracaine is a particular problem in this respect. For these reasons, repeated administration of LA drops should be avoided and they should not be given to patients to take home for pain relief.
Systemic side-effects - none noted with these topical drops.
Injected anaesthetics
Examples - lidocaine hydrochloride is the most commonly used agent but individual surgeons may use other agents such as bupivacaine and cocaine.
Användning - minor operations, oculoplastic surgery, anterior segment and cataract surgery.
Contra-indications and cautions - see individual drug monographs.4 Other contra-indications for LA use in intraocular surgery include patient refusal and concurrent medical conditions preventing correct positioning of the patient. Such patients require general anaesthesia.
Administration - local subcutaneous injection to skin, subconjunctival injection, sub-Tenon injection (see below), peribulbar and retrobulbar injections. The latter two carry a greater risk of adverse effects and are not commonly used. Maximal arterial plasma concentrations vary with each drug: using longer-acting drugs is preferable to repeated injections. The drugs should not be injected into traumatised or inflamed tissues, as this increases the likelihood of systemic absorption and adverse effects.
Ocular side-effects - none from the drug if correctly administered. Peribulbar and retrobulbar injections are trickier and can result in retrobulbar haemorrhage, globe puncture, optic nerve damage, muscle palsy and seventh cranial nerve complications.5
Systemic side-effects - rare but can occur if a very large dose is injected or if a normal dose is inadvertently injected intravenously. These include vasovagal reactions, confusion, respiratory depression, convulsions, hypotension and bradycardia.
Choice of anaesthetic in ocular surgery
The choice of anaesthetic in ocular surgery depends on the procedure, the patient and, to a lesser extent, the surgeon's preference. There are wide variations in practice both across the UK and generally.
With any operation, the initial choice is between a general anaesthetic (GA) and LA. LA is used in 95% of cataract operations in the UK. When the decision is made to use an LA, the choice is between an injected anaesthesia and drops.
GA is generally considered most appropriate for children and younger cataract patients. GA is also normally offered in trauma cases and to patients who will have trouble keeping still because of, for example, significant tremor or confusion or distress.
Local anaesthetic drops
Locally applied anaesthetic drops are now generally used in cataract operations. They are easy to apply and are associated with minimal discomfort and side-effects. Their principal problem lies in the fact that they do not block muscular action. This can be an issue in procedures where movements of a millimetre or less can have serious consequences. Combinations of topical and injected LA are also used in cataract surgery.
Injected local anaesthetic6
Injected anaesthetics are routinely used for oculoplastic procedures.
Usually the LA is infiltrated directly into the skin around the operation site. For globe surgery (eg, cataract operation), LA may be administered through the lower lid and under the globe (peribulbar/retrobulbar anaesthesia). Highly effective anaesthesia and extraocular muscle block can be achieved but this method may be associated with serious complications.
Alternatively, in globe surgery, the sub-Tenon's technique involves making a very small incision in the anaesthetised conjunctiva, the passage of a pre-curved blunted needle into the space between it and the globe (the sub-Tenon's space) and infiltration of the anaesthetic.7 Good anaesthesia is achieved with generally a good muscle block. The sub-Tenon's technique is not typically used in the USA.
The sub-Tenon's technique: what to expect
If a patient is told that they will have an 'injection in the eye' (such as the local anaesthetic before cataract surgery or steroid treatment in severe uveitis), they will experience the following:
An anaesthetic drop will be administered.
A small spring will be applied to hold the lids open (painless).
A small incision will be made in the conjunctiva: they should not feel it.
They will probably feel the agent being infiltrated in: there may be a burning or stinging sensation. Some patients feel nothing.
The spring is removed and a pad is placed over the eye.
Discomfort/pain varies between individuals and depends on what is being injected.
Patients will commonly have a red eye or may have a small subconjunctival haemorrhage afterwards: this should resolve over 24-48 hours.
In both these LA techniques, pain and muscular function are affected but sight is preserved; the degree varies from one patient to another, as does the experience. Many describe seeing colours, waves and rainbow-like images.
A significant number of patients fear intra-operative visual experiences. Retrospectively, about 20% of individuals actually describe their experience as frightening (this correlates highly with pre-operative anxiety).
Risks of injected local anaesthetic6
These should be explained to the patient at the consent stage of proceedings. Generally, these are very safe techniques. Localised self-limiting haemorrhage is reasonably common but serious.
Sight-limiting complications are very rare, occurring in around 0.06% of injected LAs (operator dependent). They are 2.5 times more common in peribulbar/retrobulbar LA than with the sub-Tenon's technique and include retrobulbar haemorrhage, intravenous injection and globe perforation. Whilst there are no absolutely safe techniques, the sub-Tenon's block appears still to be the safest option to date.
Patients on anticoagulants or antiplatelet agents are at significantly increased risk of minor complications associated with injected LAs.
Agents added to ocular local anaesthetics
Fluorescein - the dye is combined with either lidocaine or proxymetacaine eyedrops, to enable visualisation of corneal epithelial defects, and used for tonometry.
Adrenaline (epinephrine) - effectively diminishes local blood flow, so decreasing systemic absorption and prolonging local effect. Very low concentrations are used (in the order of 1:80,000 to 1:200,000). This is reserved for use in injected LAs and is not added to eye drops.
Hyaluronidase - this enzyme is added to increase tissue permeability to injected fluid, usually at a concentration of 15 units/mL.
Dr Mary Lowth är en författare eller den ursprungliga författaren till denna broschyr.
Exklusiva uppdateringar för vårdpersonal
Håll dig informerad med de senaste kliniska uppdateringarna, professionella insikter och evidensbaserad vägledning. Patient Pro-nyhetsbrevet sammanställer viktigt innehåll för vårdpersonal—levererat direkt till din inkorg.
Genom att prenumerera accepterar du våra Sekretesspolicy. Du kan avsluta prenumerationen när som helst. Vi säljer aldrig dina uppgifter.
Vidare läsning och referenser
- Farrelly-Waters M, Smith J, Parmar K; The efficacy of bupivacaine for the treatment of strabismus. Strabismus. 2022 Mar;30(1):42-47. doi: 10.1080/09273972.2021.2022714. Epub 2022 Feb 11.
- Corneal superficial injury; NICE CKS, June 2022 (UK access only)
- Hamid M, Shiwani HA, Hamid F; A survey of anaesthetic preferences in cataract surgery. Int J Ophthalmol. 2022 Feb 18;15(2):342-345. doi: 10.18240/ijo.2022.02.22. eCollection 2022.
- Mediciner Komplett BNF 89:e Utgåvan; Brittiska Läkarföreningen och Kungliga Farmaceutiska Sällskapet i Storbritannien, London.
- Mahan M, Flor R, Purt B; Local And Regional Anesthesia in Ophthalmology and Ocular Trauma.
- Lodhi O, Tripathy K; Anesthesia For Eye Surgery.
- Guay J, Sales K; Sub-Tenon's anaesthesia versus topical anaesthesia for cataract surgery. Cochrane Database Syst Rev. 2015 Aug 27;2015(8):CD006291. doi: 10.1002/14651858.CD006291.pub3.
Om författarenVisa fullständig biografi

Dr Hayley Willacy, FRCGP
Allmänläkare, Medicinsk Författare
MBChB (1992), DRCOG, DFFP, MRCOG (Part 1) MRCGP (2007), DFSRH (2013), MSc - medical education (2020)
Dr Hayley Willacy var en NHS-läkare som arbetade i nordvästra England och gick i pension från klinisk praktik 2022 efter 30 år.
Om recensentenVisa fullständig biografi

Dr Toni Hazell, MRCGP
MBBS, BSc, MRCGP, DFSRH, Dip GU med, DRCOG, DCH (London, UK, 2000)
Dr. Toni Hazell tog examen från St. Mary’s Hospital Medical School och genomförde sin VTS vid Northwick Park Hospital.
Artikelhistorik
Informationen på denna sida är skriven och granskad av kvalificerade kliniker.
Artikeln finns också på Engelska, Tyska, Spanska, Franska, Italienska, Portugisiska, Hindi, Hebreiska, Arabiska, och Svenska.
Next review due: 28 Dec 2027
29 Dec 2022 | Senaste versionen

Fråga, dela, anslut.
Bläddra i diskussioner, ställ frågor och dela erfarenheter inom hundratals hälsorelaterade ämnen.

Känner du dig sjuk?
Bedöm dina symtom online gratis
Mer inom läkemedelsbehandling
- Antiinflammatoriska ögonpreparat
- Anti-tumörnekrosfaktor alfa
- Antimikrobiella ögonpreparat
- Blind behandling av bakteriell infektion
- Kalciumkanalblockerare
- Läkemedel baserade på cannabis
- Sjukdomsmodifierande antireumatiska läkemedel
- Ögonläkemedel - förskrivning och administrering
- Hib-vaccination
- Hormonbehandling
- HRT - inledande konsultation
- Influensavaccination
- Neuroleptiskt malignt syndrom
- Smärta och smärtlindring
- Premedicinering
- Förskrivning för barn
- Johannesört
- Terapeutiska immunoglobuliner
- Vacciner och immunologiska produkter